Axsome Therapeutics, Inc.: shareholders and insiders

AXSMNASDAQHealthcare · Pharmaceutical Preparations

Price

$129.36

November 20, 2026Market cap $6.6B

What Ploutos Investor adds for Axsome Therapeutics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 4 fiscal years, from 2022
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 21, 2025 to Sep 3, 2026, from their own Form 4 filings.

15 Form 4s

Bought on the market

–

nobody

Sold on the market

$113M

8 people

From Nov 21, 2025 to Nov 21, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan100%
  • The rest0%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 21, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $95M by 7 people

  • 2025: no buys, sold $18M by 2 people
  • 2026: no buys, sold $95M by 7 people
  • Sep 3, 2026Mark L. JacobsonChief Operating Officer
    Kind10b5-1
  • Sep 3, 2026Mark L. JacobsonChief Operating Officer
    Kind10b5-1
  • Aug 6, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Aug 6, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Aug 5, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Aug 5, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Jul 1, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Jul 1, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Jun 11, 2026Roger JeffsDirector
    Kind10b5-1
  • Jun 10, 2026Roger JeffsDirector
    Kind10b5-1
  • Jun 10, 2026Susan MahonyDirector
    Kind10b5-1
  • Jun 10, 2026Mark ColemanDirector
    Kind10b5-1
  • Jun 9, 2026Susan MahonyDirector
    Kind10b5-1
  • Jun 9, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Jun 9, 2026Herriot TabuteauChief Executive Officer
    Kind10b5-1
  • Jun 9, 2026Nick PizzieChief Financial Officer
    Kind10b5-1
  • Jun 9, 2026Nick PizzieChief Financial Officer
    Kind10b5-1
  • Jun 8, 2026Roger JeffsDirector
    Kind
  • Jun 8, 2026Mark E SaadDirector
    Kind
  • Jun 8, 2026Susan MahonyDirector
    Kind10b5-1
  • Jun 8, 2026Mark ColemanDirector
    Kind10b5-1
  • Jun 2, 2026Mark ColemanDirector
    Kind10b5-1
  • Jun 1, 2026Mark ColemanDirector
    Kind10b5-1
  • May 29, 2026Mark ColemanDirector
    Kind10b5-1
  • May 5, 2026Mark L. JacobsonChief Operating Officer
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 2, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by AXSM's officers and directors from 2015 up to November 20, 2025, 11 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

1 Holders over 5%Jul 27, 2026 Latest filing
  • BlackRock, Inc.
    Share of class5.30%
Fell to 5% or less (2)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • The Vanguard Group0.00%Mar 26, 202613G/A
  • RTW Investments, LP3.10%Aug 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Millennium Mgmt (Englander)
    In the quarter+138%
  • Bridgewater (Dalio)
    In the quarter+116%
  • D.E. Shaw
    In the quarter+4.3%
  • Renaissance Technologies
    In the quarter-21%
  • Point72 (Cohen)
    In the quarter-63%
  • AQR Capital
    In the quarter+392%
  • Citadel Advisors (Griffin)
    In the quarter-92%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 6.08% of its shares outstanding were held short, -5.9% since the report before.

Shares held short
3.11M
6.08%
Since the report before3.31M on Sep 30, 2026
-5.9%
3.3
932.5K
More days to cover thanof 4,578 US-listed companies with enough volume
39%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 7.35M
  • Nov 15, 2023: Shares held short 7.64M
  • Nov 30, 2023: Shares held short 8.45M
  • Dec 15, 2023: Shares held short 8.36M
  • Dec 29, 2023: Shares held short 8.42M
  • Jan 12, 2024: Shares held short 8.32M
  • Jan 31, 2024: Shares held short 7.49M
  • Feb 15, 2024: Shares held short 7.52M
  • Feb 29, 2024: Shares held short 7.47M
  • Mar 15, 2024: Shares held short 7.30M
  • Mar 28, 2024: Shares held short 7.65M
  • Apr 15, 2024: Shares held short 7.75M
  • Apr 30, 2024: Shares held short 7.71M
  • May 15, 2024: Shares held short 7.59M
  • May 31, 2024: Shares held short 8.27M
  • Jun 14, 2024: Shares held short 8.89M
  • Jun 28, 2024: Shares held short 8.58M
  • Jul 15, 2024: Shares held short 8.28M
  • Jul 31, 2024: Shares held short 8.14M
  • Aug 15, 2024: Shares held short 7.67M
  • Aug 30, 2024: Shares held short 7.61M
  • Sep 13, 2024: Shares held short 7.67M
  • Sep 30, 2024: Shares held short 7.76M
  • Oct 15, 2024: Shares held short 7.52M
  • Oct 31, 2024: Shares held short 7.58M
  • Nov 15, 2024: Shares held short 7.69M
  • Nov 29, 2024: Shares held short 7.08M
  • Dec 13, 2024: Shares held short 6.52M
  • Dec 31, 2024: Shares held short 6.62M
  • Jan 15, 2025: Shares held short 5.75M
  • Jan 31, 2025: Shares held short 5.61M
  • Feb 14, 2025: Shares held short 5.87M
  • Feb 28, 2025: Shares held short 5.71M
  • Mar 14, 2025: Shares held short 4.91M
  • Mar 31, 2025: Shares held short 5.15M
  • Apr 15, 2025: Shares held short 4.42M
  • Apr 30, 2025: Shares held short 4.20M
  • May 15, 2025: Shares held short 3.89M
  • May 30, 2025: Shares held short 3.88M
  • Jun 13, 2025: Shares held short 4.02M
  • Jun 30, 2025: Shares held short 4.08M
  • Jul 15, 2025: Shares held short 3.63M
  • Jul 31, 2025: Shares held short 3.67M
  • Aug 15, 2025: Shares held short 3.72M
  • Aug 29, 2025: Shares held short 3.51M
  • Sep 15, 2025: Shares held short 3.45M
  • Sep 30, 2025: Shares held short 3.38M
  • Oct 15, 2025: Shares held short 3.44M
  • Oct 31, 2025: Shares held short 3.60M
  • Nov 14, 2025: Shares held short 3.39M
  • Nov 28, 2025: Shares held short 3.40M
  • Dec 15, 2025: Shares held short 2.84M
  • Dec 31, 2025: Shares held short 2.72M
  • Jan 15, 2026: Shares held short 2.71M
  • Jan 30, 2026: Shares held short 2.71M
  • Feb 13, 2026: Shares held short 2.71M
  • Feb 27, 2026: Shares held short 2.59M
  • Mar 13, 2026: Shares held short 2.76M
  • Mar 31, 2026: Shares held short 2.83M
  • Apr 15, 2026: Shares held short 2.68M
  • Apr 30, 2026: Shares held short 2.75M
  • May 15, 2026: Shares held short 2.78M
  • May 29, 2026: Shares held short 3.09M
  • Jun 15, 2026: Shares held short 3.28M
  • Jun 30, 2026: Shares held short 2.63M
  • Jul 15, 2026: Shares held short 3.02M
  • Jul 31, 2026: Shares held short 3.41M
  • Aug 14, 2026: Shares held short 3.21M
  • Aug 31, 2026: Shares held short 3.08M
  • Sep 15, 2026: Shares held short 3.14M
  • Sep 30, 2026: Shares held short 3.31M
  • Oct 15, 2026: Shares held short 3.11M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading57.5% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 57.5% of the shares in the reported trades were short sales, against 55.4% in the 14 before.

Last 14 sessionsNov 3, 2026 – Nov 20, 2026
57.5%
The 14 beforeOct 14, 2026 – Nov 2, 2026
55.4%
Change
+2.1 pts
Short sales a dayon average, of 407.4K shares
234.2K
More than atof 3,674 US-listed companies, same days
76%
Median of alleight in ten from 34.4% to 63.9%
50.5%
  • Oct 14, 2026: Short sales 43.1%
  • Oct 15, 2026: Short sales 58.4%
  • Oct 16, 2026: Short sales 55.8%
  • Oct 19, 2026: Short sales 42%
  • Oct 20, 2026: Short sales 66.9%
  • Oct 21, 2026: Short sales 66.4%
  • Oct 22, 2026: Short sales 58.9%
  • Oct 23, 2026: Short sales 65%
  • Oct 26, 2026: Short sales 54.9%
  • Oct 27, 2026: Short sales 34%
  • Oct 28, 2026: Short sales 53.5%
  • Oct 29, 2026: Short sales 59%
  • Oct 30, 2026: Short sales 60.1%
  • Nov 2, 2026: Short sales 55.4%
  • Nov 3, 2026: Short sales 69.7%
  • Nov 4, 2026: Short sales 56.2%
  • Nov 5, 2026: Short sales 51.3%
  • Nov 6, 2026: Short sales 68.9%
  • Nov 9, 2026: Short sales 46.3%
  • Nov 10, 2026: Short sales 64.2%
  • Nov 11, 2026: Short sales 65.3%
  • Nov 12, 2026: Short sales 63.1%
  • Nov 13, 2026: Short sales 27.4%
  • Nov 16, 2026: Short sales 60.9%
  • Nov 17, 2026: Short sales 46.9%
  • Nov 18, 2026: Short sales 63.3%
  • Nov 19, 2026: Short sales 60%
  • Nov 20, 2026: Short sales 54%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

151.4K Insiders' shares0.30% Of the company
  • Roger JeffsDirector
    Directly58.4K
  • Nick PizzieChief Financial Officer
    Directly42.9K
  • Mark ColemanDirector
    Directly30.4K
  • Mark E SaadDirector
    Directly11.7K
  • Herriot TabuteauChief Executive Officer
    Directly7,229
  • Susan MahonyDirector
    Directly829
  • Mark L. JacobsonChief Operating Officer
    Directly–
  • Ari MaizelChief Commercial Officer
    Directly–
  • Hunter R. MurdockGeneral Counsel
    Directly–

A lower bound: it counts only the 9 officers and directors with a market trade since Nov 22, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

24 ETFs holding it2.42% The largest weight (IHE)
  • IHEiShares U.S. Pharmaceuticals ETF
    Weight in the fund2.42%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.82%
  • PPHVanEck Pharmaceutical ETF
    Weight in the fund0.77%
  • FESMFidelity Enhanced Small Cap Core ETF
    Weight in the fund0.63%
  • VBKVanguard Small-Cap Growth Index Fund
    Weight in the fund0.30%
  • IWPiShares Russell Mid-Cap Growth ETF
    Weight in the fund0.29%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.18%
  • IYHiShares U.S. Healthcare ETF
    Weight in the fund0.15%
  • VBVanguard Small-Cap Index Fund
    Weight in the fund0.13%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.12%

24 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

506 Managers, Q2 2026$9.5B Value of their positions
  • Q3 2025: Managers 356
  • Q4 2025: Managers 400
  • Q1 2026: Managers 413
  • Q2 2026: Managers 506

Institutional investors by quarter

The fund managers holding AXSM, quarter by quarter, from Q4 2015 to Q2 2025, 39 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 506 managers held 38.66M shares, worth $9.5B. During the quarter 138 opened a position, 45 closed one, 157 added and 153 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter-21%
  • Vanguard Portfolio Management
    In the quarter-3.6%
  • Vanguard Capital Management
    In the quarter+1.4%
  • Invesco
    In the quarter+29%
  • FMR
    In the quarter-1.8%
  • Geode Capital Management
    In the quarter-17%
  • Assenagon Asset Management
    In the quarter+5.0%
  • Morgan Stanley
    In the quarter+69%
  • State Street
    In the quarter-20%
  • Deep Track Capital
    In the quarter-36%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Axsome Therapeutics's filings show?

Who buys and sells is one part of Axsome Therapeutics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about AXSM's shareholders

Didn't find what you were looking for?

Ask us
Have AXSM's insiders bought or sold?

From Jun 2, 2026 to Sep 3, 2026 Axsome Therapeutics's insiders bought 0 and sold $49M of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold AXSM?

7 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $244M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.